文献速递心脏核医学

肝移植候选者的冠心病危险因素、运动能力和单光子发射计算机断层显像的预后价值:一项5年随访研究

Prognostic value of coronary risk factors, exercise capacity and single photon emission computed tomography in liver transplantation candidates: A 5-year follow-up study.
PubMed 文献 · J Nucl Cardiol · 2020-05-11

本研究纳入404例连续终末期肝病患者,在等待肝移植前接受锝-99m SPECT及冠状动脉钙化评分,其中158例后续接受移植并纳入主要分析。随访平均5.4年,异常灌注与心血管死亡增加相关(P=0.014),且为心血管死亡(校正HR 4.2)和主要不良心血管事件的独立预测因子(校正HR 7.7);钙化评分与灌注异常程度及结局均无关联。

要点

  • 肝移植后多数死亡(78%)为非心血管原因,但异常灌注在此高危人群中常见(20%)。
  • 异常灌注是心血管死亡(校正HR 4.2)和MACE(校正HR 7.7)的独立预测因子。
  • 异常灌注合并不能运动>4 METs者全因死亡生存率最低(P=0.038)。

核心结论

  • 肝移植后大多数死亡为非心血管原因,但异常灌注在此高危人群中常见,且较功能状态是心血管疾病发病和死亡的更强预测因子。
  • 功能状态与心肌灌注联合评估可识别全因死亡风险最高者。

研究设计与样本

  • 研究纳入404例连续终末期肝病患者,在等待肝移植前转诊至一所大学医院接受心血管风险分层。
  • 所有受试者至少符合以下一条标准:病史不能完成>4 METs(62%)、胰岛素治疗糖尿病(53%)、血清肌酐>1.72 mg/dL(8%)、心肌梗死/PCI/CABG史(5%)、稳定型心绞痛(3%)、脑血管病(1%)、外周血管病(1%)。
  • 受试者接受锝-99m SPECT及多层冠状动脉钙化评分,采用运动平板或对不能达到85%最大心率者采用标准腺苷负荷(Siemens Symbia T16)。
  • 404例中158例(年龄59±9岁;男性68%)后续接受移植并纳入主要分析。

主要发现

  • 158例中50例(32%)在平均5.4年随访(最长10.9年)后死亡,多数死亡(78%)归因于非心血管原因(恶性肿瘤、脓毒症、肾功能衰竭)。
  • 32例(20%)存在异常灌注,其中9例(6%)为高危灌注异常,定义为总灌注缺损面积≥15%和/或缺血灌注缺损面积≥10%。
  • Kaplan-Meier生存曲线显示异常灌注与心血管死亡增加相关(generalized Wilcoxon,P=0.014),但与全因死亡无关。
  • 异常灌注合并不能运动>4 METs者全因死亡生存率最低(P=0.038)。
  • 在包含年龄、性别、糖尿病、吸烟和运动>4 METs能力的多变量Cox回归模型中,异常灌注是心血管死亡的强独立预测因子(校正HR 4.2;95%CI 1.4至12.3;P=0.019)和MACE的强独立预测因子(校正HR 7.7;95%CI 1.4至42.4;P=0.018)。

关键数值与推荐

  • 异常灌注定义为 summed stress score(SSS)≥4。
  • 高危灌注异常定义为总灌注缺损面积≥15%和/或缺血灌注缺损面积≥10%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although consensus-based guidelines support noninvasive stress testing prior to orthotopic liver transplantation (OLT), the optimal screening strategy for assessment of coronary artery disease in patients with end-stage liver disease (ESLD) is unclear. This study sought to determine the relative predictive value of coronary risk factors, functional capacity, and single photon emission computed tomography (SPECT) on major adverse cardiovascular events and all-cause mortality in liver transplantation candidates. METHODS: Prior to listing for transplantation, 404 consecutive ESLD patients were referred to a University hospital for cardiovascular (CV) risk stratification. All subjects met at least one of the following criteria: inability to perform > 4 METs by history (62%), insulin-treated diabetes mellitus (53%), serum creatinine > 1.72 mg/dL (8%), history of MI, PCI or CABG (5%), stable angina (3%), cerebrovascular disease (1%), peripheral vascular disease (1%). Subjects underwent Technetium-99m SPECT with multislice coronary artery calcium scoring (CACS) using exercise treadmill or standard adenosine stress in those unable to achieve 85% maximal heart rate (Siemens Symbia T16). Abnormal perfusion was defined as a summed stress score (SSS) ≥ 4. RESULTS: Of the 404 patients, 158 (age 59 ± 9 years; male 68%) subsequently underwent transplantation and were included in the primary analysis. Of those, 50 (32%) died after a mean duration follow-up of 5.4 years (maximal 10.9 years). Most deaths (78%) were attributed to noncardiovascular causes (malignancy, sepsis, renal failure). Of the 32 subjects with abnormal perfusion (20%), nine (6%) had a high-risk perfusion abnormality defined as a total perfusion defect size (PDS) ≥ 15% and/or an ischemic PDS ≥ 10%. Kaplan-Meier survival curves demonstrated abnormal perfusion was associated with increased CV mortality (generalized Wilcoxon, P = 0.014) but not all-cause death. Subjects with both abnormal perfusion and an inability to exercise > 4 METs had the lowest survival from all-cause death (P = 0.038). Abnormal perfusion was a strong independent predictor of CV death (adjusted HR 4.2; 95% CI 1.4 to 12.3; P = 0.019) and MACE (adjusted HR 7.7; 95% CI 1.4 to 42.4; P = 0.018) in a multivariate Cox regression model that included age, sex, diabetes, smoking and the ability to exercise > 4 METs. There was no association between CACS and the extent of perfusion abnormality, nor with outcomes. CONCLUSIONS: Most deaths following OLT are noncardiovascular. Nonetheless, abnormal perfusion is prevalent in this high-risk population and a stronger predictor of cardiovascular morbidity and mortality than functional status. A combined assessment of functional status and myocardial perfusion identifies those at highest risk of all-cause death. (Exercise Capacity and Single Photon Emission Computed Tomography in Liver Transplantation Candidates [ExSPECT]; ClinicalTrials.gov Identifier: NCT03864497).

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Moody WE, Holloway B, Arumugam P, et al. Prognostic value of coronary risk factors, exercise capacity and single photon emission computed tomography in liver transplantation candidates: A 5-year follow-up study. J Nucl Cardiol. 2020. PMID: 32394403. doi:10.1007/s12350-020-02126-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。